Roles of the kallikrein/kinin system in the adaptive immune system

International Immunopharmacology

Volumn 8, Issue 2, 2008, Pages 155-160

  Schulze Topphoff, U ^a,c   Prat, A ^b   Bader, M ^c   Zipp, F ^a,c   Aktas, O ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Autoimmunity; Bradykinin; Experimental autoimmune encephalomyelitis; Immune system; Multiple sclerosis

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ RECEPTOR; KALLIKREIN; KININ; OCTAPEPTIDE;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CARDIOVASCULAR SYSTEM; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; DENDRITIC CELL; DRUG TARGETING; ENDOTHELIUM CELL; EXPERIMENTAL STUDY; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; KALLIKREIN KININ SYSTEM; MACROPHAGE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TREATMENT PLANNING;

ANIMALS; AUTOIMMUNE DISEASES; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; KALLIKREIN-KININ SYSTEM; LYMPHOCYTES; RECEPTORS, BRADYKININ;

EID: 37549023007     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.08.001     Document Type: Article

References (58)

1. Calixto J.B., Medeiros R., Fernandes E.S., Ferreira J., Cabrini D.A., and Campos MM. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 143 7 (2004) 803-818
2. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44 1 (1992) 1-80
3. Merino V.F., Silva Jr. J.A., Araujo R.C., Avellar M.C., Bascands J.L., Schanstra J.P., et al. Molecular structure and transcriptional regulation by nuclear factor-kappaB of the mouse kinin B1 receptor gene. Biol Chem 386 6 (2005) 515-522
4. Rehli M., Krause S.W., Kreutz M., and Andreesen R. Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J Biol Chem 270 26 (1995) 15644-15649
5. Bockmann S., and Paegelow I. Kinins and kinin receptors: importance for the activation of leukocytes. J Leukoc Biol 68 5 (2000) 587-592
6. Aliberti J., Viola J.P., Vieira-de-Abreu A., Bozza P.T., Sher A., and Scharfstein J. Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J Immunol 170 11 (2003) 5349-5353
7. Monteiro A.C., Schmitz V., Svensjo E., Gazzinelli R.T., Almeida I.C., Todorov A., et al. Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J Immunol 177 9 (2006) 6325-6335
8. Bertram C.M., Baltic S., Misso N.L., Bhoola K.D., Foster P.S., Thompson P.J., et al. Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration. J Leukoc Biol 81 6 (2007) 1445-1454
9. Bechmann I., Goldmann J., Kovac A.D., Kwidzinski E., Simburger E., Naftolin F., et al. Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia. FASEB J 19 6 (2005) 647-649
10. Noda M., Kariura Y., Pannasch U., Nishikawa K., Wang L., Seike T., et al. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem 101 2 (2007) 397-410
11. Infante-Duarte C., Horton H.F., Byrne M.C., and Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165 11 (2000) 6107-6115
12. Nogai A., Siffrin V., Bonhagen K., Pfueller C.F., Hohnstein T., Volkmer-Engert R., et al. Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells. J Immunol 175 2 (2005) 959-966
13. Prat A., Weinrib L., Becher B., Poirier J., Duquette P., Couture R., et al. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology 53 9 (1999) 2087-2092
14. Davidson A., and Diamond B. Autoimmune diseases. N Engl J Med 345 (2001) 340-350
15. Kamradt T., and Mitchison A. Tolerance and autoimmunity. N Engl J Med 344 (2001) 655-664
16. Antel J., and Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J Neuroimmunol 180 1-2 (2006) 3-8
17. Petkova S.B., Konstantinov K.N., Sproule T.J., Lyons B.L., Awwami M.A., and Roopenian DC. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIIB. J Exp Med 203 2 (2006) 275-280
18. Blank M., Cohen J., Toder V., and Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 88 8 (1991) 3069-3073
19. Toyka K.V., Brachman D.B., Pestronk A., and Kao I. Myasthenia gravis: passive transfer from man to mouse. Science 190 4212 (1975) 397-399
20. Khachigian L.M. Collagen antibody-induced arthritis. Nat Protoc 1 5 (2006) 2512-2516
21. Cromartie W.J., Craddock J.G., Schwab J.H., Anderle S.K., and Yang C.H. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 146 6 (1977) 1585-1602
22. La Cadena R.A., Laskin K.J., Pixley R.A., Sartor R.B., Schwab J.H., Back N., et al. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am J Physiol 260 2 Pt 1 (1991) G213-G219
23. Paterson P.Y. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111 (1960) 119-136
24. Wekerle H., Linington C., Lassmann H., and Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci 9 (1986) 271-277
25. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol 2 (2001) 762-764
26. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 6924 (2003) 744-748
27. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 2 (2005) 233-240
28. Hofstetter H.H., Toyka K.V., Tary-Lehmann M., and Lehmann PV. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J Immunol 178 3 (2007) 1372-1378
29. Aktas O., Schulze-Topphoff U., and Zipp F. The role of TRAIL/TRAIL receptors in central nervous system pathology. Front Biosci 12 (2007) 2912-2921
30. Aktas O., Prozorovski T., and Zipp F. Death ligands and autoimmune demyelination. Neuroscientist 12 (2006) 305-316
31. Hemmer B., Archelos J.J., and Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3 4 (2002) 291-301
32. Zipp F., and Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 29 9 (2006) 518-527
33. Peterson J.W., Bo L., Mork S., Chang A., and Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50 (2001) 389-400
34. Aktas O., Smorodchenko A., Brocke S., Infante-Duarte C., Topphoff U.S., Vogt J., et al. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 46 3 (2005) 421-432
35. Aktas O., Ullrich O., Infante-Duarte C., Nitsch R., and Zipp F. Neuronal damage in brain inflammation. Arch Neurol 64 2 (2007) 185-189
36. Frohman E.M., Racke M.K., and Raine C.S. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 354 9 (2006) 942-955
37. Linington C., Bradl M., Lassmann H., Brunner C., and Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130 (1988) 443-454
38. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 23 (2005) 683-747
39. Rohn T.A., Jennings G.T., Hernandez M., Grest P., Beck M., Zou Y., et al. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 36 11 (2006) 2857-2867
40. Constantinescu C.S., Goodman D.B., Grossman R.I., Mannon L.J., and Cohen JA. Serum angiotensin-converting enzyme in multiple sclerosis. Arch Neurol 54 8 (1997) 1012-1015
41. Schweisfurth H., Kment A., Dahlheim H., and Strauer B.E. Elevated angiotensin-I-converting enzyme (ACE) in patients with essential hypertension. Klin Wochenschr 60 1 (1982) 49-50
42. Lovrecic L., Ristic S., Starcevic-Cizmarevic N., Jazbec S.S., Sepcic J., Kapovic M., et al. Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis. Acta Neurol Scand 114 6 (2006) 374-377
43. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8 5 (2002) 500-508
44. Prat A., Biernacki K., Pouly S., Nalbantoglu J., Couture R., and Antel J.P. Kinin B1 receptor expression and function on human brain endothelial cells. J Neuropathol Exp Neurol 59 10 (2000) 896-906
45. Emerich D.F., Dean R.L., Osborn C., and Bartus R.T. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation. Clin Pharmacokinet 40 2 (2001) 105-123
46. Prat A., Biernacki K., Saroli T., Orav J.E., Guttmann C.R., Weiner H.L., et al. Kinin B1 receptor expression on multiple sclerosis mononuclear cells: correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability. Arch Neurol 62 5 (2005) 795-800
47. La Cadena R.A., Stadnicki A., Uknis A.B., Sartor R.B., Kettner C.A., Adam A., et al. Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat. FASEB J 9 5 (1995) 446-452
48. Uknis A.B., La Cadena R.A., Janardham R., Sartor R.B., Whalley E.T., and Colman R.W. Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat. Inflamm Res 50 3 (2001) 149-155
49. Sainz I.M., Uknis A.B., Isordia-Salas I., La Cadena R.A., Pixley R.A., and Colman R.W. Interactions between bradykinin (BK) and cell adhesion molecule (CAM) expression in peptidoglycan-polysaccharide (PG-PS)-induced arthritis. FASEB J 18 7 (2004) 887-889
50. Germain L., Barabe J., and Galeano C. Increased blood concentration of des-Arg9-bradykinin in experimental allergic encephalomyelitis. J Neurol Sci 83 2-3 (1988) 211-217
51. Constantinescu C.S., Ventura E., Hilliard B., and Rostami A. Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol 17 3 (1995) 471-491
52. Scarisbrick I.A., Blaber S.I., Lucchinetti C.F., Genain C.P., Blaber M., and Rodriguez M. Activity of a newly identified serine protease in CNS demyelination. Brain 125 Pt 6 (2002) 1283-1296
53. Scarisbrick I.A., Blaber S.I., Tingling J.T., Rodriguez M., Blaber M., and Christophi G.P. Potential scope of action of tissue kallikreins in CNS immune-mediated disease. J Neuroimmunol 178 1-2 (2006) 167-176
54. Blaber S.I., Ciric B., Christophi G.P., Bernett M.J., Blaber M., Rodriguez M., et al. Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease. FASEB J 18 7 (2004) 920-922
55. Angelo P.F., Lima A.R., Alves F.M., Blaber S.I., Scarisbrick I.A., Blaber M., et al. Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects. J Biol Chem 281 6 (2006) 3116-3126
56. Debela M., Magdolen V., Schechter N., Valachova M., Lottspeich F., Craik C.S., et al. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J Biol Chem 281 35 (2006) 25678-26788
57. Campos M.M., Leal P.C., Yunes R.A., and Calixto J.B. Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci 27 12 (2006) 646-651
58. Marceau F., and Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3 10 (2004) 845-852